Evaluation of the effectiveness of targeted lookback for HCV infection in the United States—interim results

Abstract

Targeted lookback related to previous multiantigen screening of donors will identify <1 percent of the estimated 300,000 HCV-positive persons in the United States who may have acquired their infection via blood transfusion.